Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage
Part of paid clinical trials in Louisville, Kentucky.
- Sponsor
- University of Louisville
- Study ID
- NCT07250958
- Status
- Recruiting
Conditions
- Aneurysmal Subarachnoid Hemorrhage
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The DOME study is a clinical trial exploring a new treatment approach for patients who suffered a severe brain bleed due to an aneurysm.
Key Dates
- Start date
- Mar 12, 2026
- Status verified
- May 2026
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 30 participants (estimated)
Primary Outcome Measure
Re-rupture incidence [ Time Frame: From procedure to 90-days post procedure. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Louisville Hospital | Louisville | Kentucky | 40202 | Akshitkumar Mistry, mD Akshitkumar Mistry, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Louisville, KY
By research site
Related Studies
- Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH)PHASE2 · Recruiting · Aditya S. Pandey, MD · Ann Arbor, Michigan
- The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageNot Yet Recruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular EventsPHASE1 · Recruiting · University of Florida · Gainesville, Florida
- The Effect of Transcutaneous Vagal Nerve Stimulation (tVNS) on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageNot Yet Recruiting · Marshall Holland · Birmingham, Alabama